Full-Time

Quality Assurance Specialist

Care Access

Care Access

501-1,000 employees

Global health education, access, and research

Compensation Overview

$70k - $90k/yr

No H1B Sponsorship

Remote in USA

Remote

Remote within the United States, with up to 35% travel, including possible international travel.

Bachelor's

Category
Biology & Biotech (1)
Required Skills
FDA Regulations
Medical Terminology
Word/Pages/Docs
Quality Assurance (QA)
Excel/Numbers/Sheets

Get referred to Care Access

See people who can refer or advise you

Requirements
  • A Bachelor’s degree.
  • At least 2 years of experience in Quality Assurance.
  • At least 4 years of experience in Clinical Research working in a compliance or Good Clinical Practice-relevant role.
  • Excellent working knowledge of medical and research terminology.
  • Excellent working knowledge of federal regulations and Good Clinical Practice.
  • Attention to detail.
  • Ability to communicate and work effectively with a diverse team of professionals.
  • Strong organizational skills, including the ability to prioritize, delegate, direct, support, and evaluate others’ work and follow through on assignments.
  • Strong verbal and written communication skills, demonstrated through positive interactions with coworkers, management, clients, and vendors.
  • Strong computer skills, including use of clinical trials databases, interactive voice response systems, electronic data capture, Microsoft Word, and Microsoft Excel.
  • Ability to balance tasks with competing priorities.
  • Decision-making skills, curiosity, willingness to learn and innovate, and ability to communicate potential risks and complete work.
  • Ability to maintain a positive attitude under pressure.
  • High level of self-motivation and energy.
  • Ability to work independently in a fast-paced environment with minimal supervision.
  • Client service mentality.
  • Experience supporting multiple sites and identifying gaps.
  • Experience with internal and external audits involving the Food and Drug Administration, Good Clinical Practice, and Standard Operating Procedures.
  • Ability to travel, including possible international travel.
Responsibilities
  • Monitor the quality and compliance of clinical work at traditional trial sites and decentralized trials.
  • Support quality initiatives, audit functions, Corrective and Preventive Action systems, and inspection readiness.
  • Ensure patient safety and data integrity at clinical research sites through regular quality assurance reviews and implementation of standard quality assurance procedures.
  • Review study-specific regulatory binders and clinical documents for accurate completion, submission, and maintenance according to Good Clinical Practice standards.
  • Execute the yearly corporate audit plan, track quality assurance audits and related activities, and prepare outcome reports for management.
  • Partner with research staff and Principal Investigators to resolve compliance issues and develop, track, and monitor Corrective and Preventive Action plans.
  • Coordinate and provide operational support for on-site audits and inspections conducted by external providers, sponsors, and regulatory agencies.
  • Maintain internal quality systems, compliance trackers, and operational programs.
  • Participate in reviewing, drafting, and maintaining quality assurance Standard Operating Procedures.
  • Provide quality guidance and best-practice recommendations to site personnel and clinical project teams.
  • Interpret regulatory guidance, including 21 CFR Part 11, 21 CFR Part 312, and ICH Good Clinical Practice E6 (R3).
  • Promote inspection readiness and continuous improvement while working with risk-based audit agendas and shifting priorities.
  • Create and deliver training on quality and improvement activities.
  • Support completion of requests for proposals and requests for information.
  • Provide quality support and consultation for artificial intelligence projects.
  • Support management of the Quality Management System and data accuracy.
  • Support Good Clinical Practice and non-Good Clinical Practice quality issues and projects requiring quality consultation and support.

Care Access coordinates global efforts to improve health by educating people about health, helping them access needed resources, and enabling participation in medical research to develop new medicines and cures. Its approach involves a global network and services that educate individuals, connect them with health resources, and recruit participants for clinical studies, thereby supporting the development of new treatments. Unlike companies that focus on a single market or product, Care Access operates worldwide and focuses on easing access to information, services, and research opportunities for diverse populations. The goal is to make health information and access more available and participation in health studies easier, with the aim of making the future of health better for everyone.

Company Size

501-1,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Boston, Massachusetts

Founded

2016

Get referred to Care Access

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Walmart opened first Care Access sites in Texas and Georgia on 2026-04-29.
  • Care Access reported 852 employees and 163 active 2026 job postings.
  • The company added Warsaw in 2024 and CEMEC in Brazil in 2025.

What critics are saying

  • Walmart locations in Houston, Tyler, and Dalton hinge on flawless spring 2026 execution.
  • Pfizer and Valneva blamed Care Access in 2023; sponsor trust remains fragile.
  • If a major sponsor exits after a compliance failure, the decentralized model collapses.

What makes Care Access unique

  • Care Access pairs community screenings with Phase 2-4 trials inside Walmart stores, 2026.
  • Its decentralized model uses mobile clinics, Sites On Demand, and local partnerships globally.
  • Brazil, Poland, and U.S. sites create a geographically distributed recruitment engine.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Paid Vacation

Paid Holidays

401(k) Retirement Plan

401(k) Company Match

Growth & Insights and Company News

Headcount

6 month growth

-4%

1 year growth

-4%

2 year growth

-4%
8th & Walton
Apr 29th, 2026
Walmart brings clinical trials into the community - walmart.com.

Walmart brings clinical trials into the community - walmart.com. Walmart is bringing clinical research into everyday community spaces through the Walmart Healthcare Research Institute and a new Clinical Trial Center collaboration with Care Access. Key takeaways. * Research closer to home: The Clinical Trial Center by Walmart and Care Access is opening initial sites in Houston and Tyler, Texas, and Dalton, Georgia, placing trial locations inside familiar store environments. * Focus on underserved communities: Walmart Healthcare Research Institute was created to expand access to clinical trials and improve care for communities historically underrepresented in research. * New model for medical innovation: Care Access will run screenings and trials, while Walmart supports outreach, with leaders describing the effort as a new way to deliver clinical research.

SmartBrief
Jan 22nd, 2026
Walmart, Care Access to partner on clinical research

Walmart, Care Access to partner on clinical research. Walmart will partner with Care Access to launch a clinical research initiative this spring that will bring clinical trial opportunities to markets, including rural areas that often lack access to cutting-edge medical research. The retailer will open research sites at select stores and former Walmart Health clinic locations. By using familiar community spaces, Walmart hopes to make participation in clinical research more accessible and convenient for local residents. Designed specifically for retail professionals, NRF SmartBrief is a free, daily email newsletter. It provides the latest need-to-know news and industry information that maximizes your time, giving you an edge over your competition.

First Free Church Chicago
Dec 1st, 2024
Care Access Senior Fair | December 6 + 7

On December 6th and 7th Firstfree is partnering with Care Access, an organization with a mission to connect the community with equitable health research.

Business Wire
Mar 18th, 2024
Care Access Opens New Clinical Research Site In Warsaw, Poland

BOSTON--(BUSINESS WIRE)--Care Access, a global clinical research site company helping to accelerate the future of medicine, has opened its newest research site in Warsaw, Poland. The company’s expansion in Poland reinforces its commitment to improving access to clinical research globally through its innovative model of bringing clinical trials wherever they are needed. In recent years, Care Access has been active in clinical research across Europe, and now, by establishing a new facility in Warsaw, Care Access is further expanding its European services aimed to implement its industry-leading research capabilities, such as its Community Screening Program, Sites On Demand, and Mobile Research Site Infrastructure. These capabilities have shown to accelerate research study enrollment by adapting to the unique makeup of each community and providing more convenient ways to participate in clinical trials. “Poland plays an important role in bringing the future of medicine to reality,” said Rupi Bancil, Senior Vice President of Global Study Operations Expansion for Care Access. “The Warsaw site will improve access to advanced health screenings and research opportunities to communities throughout Poland.”

Business Wire
Mar 4th, 2024
New Study Addressing Global Concern For Breast Cancer Treatment Now Available In Clifton, N.J.

BOSTON--(BUSINESS WIRE)--A cancer research study focusing on hormone receptor-positive HER2-negative (HR+/HER2-) metastatic breast cancer (MBC) is now available to patients in the Clifton, N.J., area. The SERENA-6 trial, sponsored by AstraZeneca, is a global study that aims to address a critical issue faced by many patients: their treatments become less effective over time. In advanced breast cancer, patients receive a treatment that combines an estrogen-reducing drug with a drug that slows cancer cell growth. While this combination works well, over time, it may stop working because of mutations in the ESR1 gene. This study will evaluate if an experimental trial drug, combined with a cancer-slowing drug, might work better than conventional estrogen-reducing drugs for patients with ESR1 mutations